Henry Schein (HSIC) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($692K), but sales were much larger ($8.6M) over the same 12 months.
Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Purchase William K. Daniel, Director bought 10,000 shares at $69.19 ($692K).
- Trade date
- May 11, 2026
- Disclosed to the SEC
- May 12, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All HSIC insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
HSIC insider transactions (Form 4)
Open-market purchases and sales. 61 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 12SEC | William K. DanielDirectorStake +100% | Buy | 10,00020,000 held (+100%) | $69.19 | $692K | +21.3% | — |
| Mar 20SEC | Thomas C. PopeckCEO | Sell | 1,35586,182 held (−2%) | $72.79 | $99K | +15.3% | — |
| Mar 11SEC | Kurt P. KuehnDirector | Sell | 2,84415,420 held (−16%) | $78.96 | $225K | +6.3% | — |
| Mar 6SEC | Mark E. MlotekEvp, Chief Strategic Officer | Sell | 4,10082,379 held (−5%) | $80.80 | $331K | +3.9% | — |
| Mar 6SEC | Philip A. LaskawyDirector | Sell | 2,84421,961 held (−11%) | $80.36 | $229K | +4.5% | — |
| Mar 6SEC | Mark E. MlotekEvp, Chief Strategic Officer | Sell | 1,82580,554 held (−2%) | $80.81 | $147K | +3.9% | — |
| Mar 3SEC | Stanley M. BergmanCEO, Chair | Sell | 23,858403,757 held (−6%) | $81.31 | $1.9M | +3.2% | — |
| Mar 3SEC | Stanley M. BergmanCEO, Chair | Sell | 19,954383,803 held (−5%) | $81.31 | $1.6M | +3.2% | — |
| Feb 27SEC | Stanley M. BergmanCEO, Chair | Sell | 31,134434,827 held (−7%) | $80.90 | $2.5M | +3.8% | — |
| Feb 27SEC | Stanley M. BergmanCEO, Chair | Sell | 10,785309,092 held (−3%) | $81.20 | $876K | +3.4% | — |
| Feb 27SEC | Stanley M. BergmanCEO, Chair | Sell | 7,212427,615 held (−2%) | $81.51 | $588K | +3.0% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for HSIC's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with HSIC in the Research Lab
Pre-set to HSIC's latest insider buy of $10K or more (May 12, 2026: William K. Daniel, $692K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
- After HSIC's buys7, 30 and 90 days later, losses included
- Find buys like this"insiders bought over $250K in the last 12 months"
- Compare HSIC vs KODInsider buying and selling side by side
- HSIC's board links4 companies share insiders with HSIC
- Play Insider Call5 real buys a day: guess which beat the market
Share price and insider trades
Henry Schein insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $692K and 5 sold $8.6M of HSIC stock on the open market; P/E 23.1 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
HSIC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $692K | 1 | — | 0 |
| Q1 2026 | — | 0 | $8.6M | 10 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 Henry Schein insider reported open-market purchases totaling $692K, while 5 insiders reported sales totaling $8.6M. Among insiders with enough purchase history to measure, Robert J. Hombach (Director) has the highest Insider Score at 79. 0 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
HSIC earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 3, 2026 | +0.3% | None | +1.9%S&P +2.0% | pending |
| Aug 4, 2026 | -1.5% | None | +3.6%S&P +1.6% | +0.2% |
| May 5, 2026 | -8.6% | None | +0.6%S&P +2.2% | +6.9% |
| Feb 24, 2026 | +1.1% | None | +1.7%S&P +1.6% | -12.0% |
| Nov 4, 2025 | +2.6% | None | +11.4%S&P -0.8% | +2.2% |
| Aug 5, 2025 | +1.3% | None | -5.3%S&P +0.3% | +4.7% |
| May 5, 2025 | +0.9% | None | +1.4%S&P -1.4% | +6.4% |
| Feb 25, 2025 | -1.7% | None | -6.6%S&P -0.4% | -5.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
HSIC short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
What happened after HSIC insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| May 12, 2026 | William K. DanielDirector | $692K | +5.1%+5.8% vs S&P | +15.7%+15.7% vs S&P | +27.0%+22.0% vs S&P |
Insiders at Henry Schein
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Stanley M. BergmanFormer Director | — | $7.5M | May 26, 2026 | — | — |
| William K. DanielDirector | $692K | — | Jun 15, 2026 | — | — |
| Mark E. MlotekEvp, Chief Strategic Officer | — | $479K | Mar 17, 2026 | — | — |
| Philip A. LaskawyDirector | — | $229K | Mar 9, 2026 | — | — |
| Kurt P. KuehnDirector | — | $225K | Mar 11, 2026 | — | — |
| Thomas C. PopeckCEO | — | $99K | Mar 20, 2026 | — | — |
| Andrea AlbertiniCEO | — | — | Sep 9, 2026 | — | — |
| Ronald N. SouthCFO | — | — | Mar 17, 2026 | — | — |
| Michael S. EttingerCOO | — | — | Mar 17, 2026 | — | — |
| Christine Zayac SheehySvp, Chief Human Res. Officer | — | — | Mar 17, 2026 | — | — |
| Frederick M. LoweryCEO | — | — | Mar 10, 2026 | — | — |
| Bradley T. ShearesDirector | — | — | Mar 9, 2026 | — | — |
| Joseph L. HerringDirector | — | — | Mar 9, 2026 | — | — |
| Deborah DerbyDirector | — | — | Mar 9, 2026 | — | — |
| Robert J. HombachDirector | — | — | Mar 9, 2026 | — | 79 |
| Reed Vaughn TucksonDirector | — | — | Mar 9, 2026 | — | — |
| Mohamad AliDirector | — | — | Mar 9, 2026 | — | — |
| Anne H. MarguliesDirector | — | — | Mar 9, 2026 | — | — |
| Carole T. FaigDirector | — | — | Mar 9, 2026 | — | — |
| Scott Philip SerotaDirector | — | — | Mar 9, 2026 | — | — |
Board links: companies that share insiders with HSIC
Directors and executives who filed Form 4s for HSIC and another company in the last 12 months.
- DDDuPont Frederick M. Lowery CEO here · Director at DD · latest filing Sep 1, 2026
- EMBCEmbecta Robert J. Hombach Director here · Director at EMBC · latest filing Aug 13, 2026
- SPTXSeaport Therapeutics Robert J. Hombach Director here · Director at SPTX · latest filing Jun 24, 2026
- TMOThermo Fisher Scientific Frederick M. Lowery CEO here · President at TMO · latest filing Mar 10, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
HSIC stock: common questions
Are Henry Schein insiders buying HSIC stock?
In the past 12 months, 1 insider reported open-market purchases of HSIC worth $692K. The latest was Director William K Daniel bought $692K of HSIC at $69.19 — first open-market purchase in our records; raises the stake by 100%.
Are Henry Schein insiders selling HSIC stock?
5 insiders reported sales worth $8.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is HSIC's P/E ratio?
HSIC trades at about 23.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is HSIC's 52-week range?
Over the past year HSIC has traded between $68.99 and $90.86. It last closed at $83.95 on Nov 19, 2026.